ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J05AB11 | G | Valaciclovir - 500mg | 5291 | 221439/08 | VALCYK BENTA | 500mg | 50 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 4,318,214 L.L | 23.08 | B | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J05AB11 | B | Valaciclovir - 500mg | 9217 | 122617/1 | VALTREX | 500mg | 10 | Tablet, film coated | Oral | Abela Frères S.A.L. | GlaxoWellcome SA | Spain | 1,169,143 L.L | 23.08 | A2 | GlaxoSmithKline Produtos Farmaceuticos Lda | Portugal | 2/5/2024 | 0 |
J05AB11 | B | Valaciclovir - 500mg | 9218 | 122517/1 | VALTREX | 500mg | 42 | Tablet, film coated | Oral | Abela Frères S.A.L. | GlaxoWellcome SA | Spain | 4,481,867 L.L | 23.08 | B | GlaxoSmithKline Produtos Farmaceuticos Lda | Portugal | 2/5/2024 | 0 |
J05AB11 | G | Valaciclovir - 500mg | 8763 | 102116/1 | VALACICLOVIR ARROW | 500mg | 10 | Tablet, film coated, breakable | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 753,896 L.L | 23.08 | A2 | Arrow Génériques | France | 2/5/2024 | 0 |
J05AB11 | G | Valaciclovir - 500mg | 9010 | 41617/1 | VALACICLOVIR ARROW | 500mg | 42 | Tablet, film coated, breakable | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 2,889,261 L.L | 23.08 | B | Arrow Génériques | France | 2/5/2024 | 0 |
J05AB11 | G | Valaciclovir - 500mg | 7120 | 166632/11 | VALCYK BENTA | 500mg | 10 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 945,809 L.L | 23.08 | A2 | 2/5/2024 | 0 |